Thrombotic Microangiopathies
"Thrombotic Microangiopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
| Descriptor ID |
D057049
|
| MeSH Number(s) |
C15.378.140.855.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thrombotic Microangiopathies".
Below are MeSH descriptors whose meaning is more specific than "Thrombotic Microangiopathies".
This graph shows the total number of publications written about "Thrombotic Microangiopathies" by people in this website by year, and whether "Thrombotic Microangiopathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 0 | 2 |
| 2020 | 3 | 1 | 4 |
| 2021 | 1 | 0 | 1 |
| 2022 | 3 | 0 | 3 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 1 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombotic Microangiopathies" by people in Profiles.
-
Soluble C5b-9 (sC5b-9) in Pediatrics-A Clinical Assessment. J Clin Lab Anal. 2025 Dec; 39(23):e70122.
-
Haemolytic uraemic syndrome. Lancet. 2022 11 12; 400(10364):1722-1740.
-
Diffuse alveolar hemorrhage: An underreported complication of transplant associated thrombotic microangiopathy. Bone Marrow Transplant. 2022 06; 57(6):889-895.
-
Incidence and Risk Factors of Transplantation-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis. Transplant Cell Ther. 2022 05; 28(5):266.e1-266.e8.
-
Therapeutic plasma exchange: single-center experience in children with kidney disorders. Pediatr Nephrol. 2021 03; 36(3):621-629.
-
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. Br J Haematol. 2020 06; 189(6):1171-1181.
-
The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy. Pediatr Blood Cancer. 2020 03; 67(3):e28070.
-
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal. Biol Blood Marrow Transplant. 2019 03; 25(3):570-576.
-
Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience. Biol Blood Marrow Transplant. 2019 01; 25(1):157-162.
-
Thrombotic microangiopathy associated with Valproic acid toxicity. BMC Nephrol. 2017 Aug 03; 18(1):262.